Main Article Content

Abstract

Adolescent-onset multiple sclerosis is uncommon and often poses diagnostic challenges due to overlap with other pediatric demyelinating disorders.[1,2] We report a well-documented case of RRMS (Relapsing–Remitting Multiple Sclerosis) in a 15-year-old girl who initially presented with unilateral optic neuritis followed six months later by brainstem–cerebellar symptoms. MRI (Magnetic Resonance Imaging) demonstrated multifocal supratentorial and infratentorialT2/FLAIR hyperintense lesions involving the brain and spinal cord, and CSF (Cerebrospinal Fluid) analysis showed positive oligoclonal bands. The diagnosis of RRMS was established using the 2017 McDonald criteria,[3] allowing early initiation of DMT (Disease Modifying Therapy) with interferon beta 1a after treatment of the acute relapse with intravenous methylprednisolone. This case highlights the educational value of timely recognition of adolescent-onset MS, application of the revised diagnostic criteria, and the importance of early DMT initiation in a resource conscious setting.


Multiple sclerosis is a chronic immune mediated demyelinating disease of the central nervous system, predominantly affecting young adults.[1,4] Pediatric-onset MS accounts for approximately 3–5% of all MS cases, with a substantial proportion presenting during adolescence rather than early childhood.[2,4,5] Compared with adult-onset disease, pediatric and adolescent MS is characterized by higher relapse rates, more inflammatory MRI lesions, and potential long-term cognitive and psychosocial consequences.[2,6] Early diagnosis is therefore critical. The 2017 revision of the McDonald criteria, including the use of CSF specific oligoclonal bands to demonstrate dissemination in time, has facilitated earlier and more confident diagnosis even after limited clinical events.[3] We present an educational case of adolescent-onset RRMS illustrating these principles.

Article Details

How to Cite
Mithun J., Pragathi Kalapala, Srinath M, & Raghavi Ravikumar. (2026). From Blurred Vision into Clarity - Unveiling the Diagnosis of Adolescent Onset Multiple Sclerosis. Journal of Evolution of Medical and Dental Sciences, 15(1), 18–21. https://doi.org/10.14260/jemds.v15i1.809

References

  1. Chitnis T. Pediatric multiple sclerosis. Neurologist 2006;12(6):299-310.
  2. Banwell B, Ghezzi A, Bar-Or A, et al. Multiple sclerosis in children: clinical diagnosis, therapeutic strategies, and future directions. Lancet Neurol 2007;6(10):887-902.
  3. Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 2018;17(2):162-73.
  4. Yeh EA, Weinstock-Guttman B. Pediatric multiple sclerosis. Curr Neurol Neurosci Rep 2006;6(3):229-34.
  5. Krupp LB, Banwell B, Tenembaum S. Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology 2007;68(16 Suppl 2):S7-12.
  6. Renoux C, Vukusic S, Mikaeloff Y, et al. Natural history of multiple sclerosis with childhood onset. N Engl J Med 2007;356(25):2603-13.
  7. Waubant E, Chabas D, Okuda DT, et al. Difference in disease burden and therapy response in pediatric and adult MS. Curr Treat Options Neurol 2011;13(3):255-69.
  8. Hacohen Y, Banwell B. Treatment approaches for demyelinating disorders in children. Curr Treat Options Neurol 2017;19(3):10.
  9. Waldman AT, Gorman MP, Rensel M, et al. Management of pediatric multiple sclerosis: current status and future prospects. Ther Adv Neurol Disord 2017;10(6):327-39.
  10. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011;69(2):292-302.